Interventional Oncology Devices | Medtech 360 | Market Analysis | Asia Pacific (Supplemental) | 2019
The Asia Pacific market for interventional oncology will expand through 2027, driven primarily by continued growth of cancer incidence, improving access to treatment, and the entry of new foreign and domestic competitors.
This Medtech 360 Report provides high-level market metrics for interventional oncology devices in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of Asia Pacific, across a 10-year period.
